ANCA-Associated Vasculitis

Hoffman GS, Calabrese LH. Vasculitis: determinants of disease patterns. Nat Rev Rheumatol. 2014 Aug;10(8):454-62. doi: 10.1038/nrrheum.2014.89. Epub 2014

Jennette JC, Falk RJ, Bacon PA, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013 Jan;65(1):1-11. doi: 10.1002/art.37715.

Salvador F. ANCA associated vasculitis. Eur J Intern Med. 2020 Apr;74:18-28. doi: 10.1016/j.ejim.2020.01.011. Epub 2020 Jan 29.

Guillevin L, Pagnoux C, Karras A, et al.; French Vasculitis Study Group.Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med. 2014 Nov 6;371(19):1771-80. doi: 10.1056/NEJMoa1404231.

Kitching AR, Anders HJ, Basu N,et al. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020 Aug 27;6(1):71. doi: 10.1038/s41572-020-0204-y.

Sattui SE, Lally L. Localized Granulomatous with Polyangiitis (GPA): Varied Clinical Presentations and Update on Treatment. Curr Allergy Asthma Rep. 2020 Jul 9;20(10):56. doi: 10.1007/s11882-020-00953-1.

Comarmond C, Cacoub P. Granulomatosis with polyangiitis (Wegener): clinical aspects and treatment. Autoimmun Rev. 2014 Nov;13(11):1121-5. doi:10.1016/j.autrev.2014.08.017. Epub 2014 Aug 20.

Petrou D, Karagiannis M, Nikolopoulos P, et al. MPO-ANCA- Positive Granulomatosis with Polyangiitis with Rapidly Progressive Glomerulonephritis and Saddle-Nose Deformity: A Case Report. Antibodies (Basel). 2022 May 9;11(2):33. doi: 10.3390/antib11020033.

Almaani S, Fussner LA, Brodsky S ,et al. ANCA-Associated Vasculitis: An Update. J Clin Med. 2021 Apr 1;10(7):1446. doi:10.3390/jcm10071446.

Chung SA, Seo P. Microscopic polyangiitis. Rheum Dis Clin North Am. 2010 Aug;36(3):545-58. doi: 10.1016/j.rdc.2010.04.003. Epub 2010 Jun 11.

White J, Dubey S. Eosinophilic granulomatosis with polyangiitis: A review. Autoimmun Rev. 2023 Jan;22(1):103219. doi: 10.1016/j.autrev.2022.103219. Epub 2022 Oct 22.

Sablé-Fourtassou R, Cohen P, Mahr A, et al. French Vasculitis Study Group. Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome. Ann Intern Med. 2005 Nov 1;143(9):632-8. doi:10.7326/0003-4819-143-9-200511010-00006

Furuta S, Iwamoto T, Nakajima H. Update on eosinophilic granulomatosis with polyangiitis. Allergol Int. 2019 Oct;68(4):430-436. doi:10.1016/j.alit.2019.06.004. Epub 2019 Jun 29.

Pagnoux C. Updates in ANCA-associated vasculitis. Eur J Rheumatol. 2016

Kawamura T, Usui J, Kaneko S,et al.Anaemia is an essential complication of ANCA-associated renal vasculitis: a single center cohort study. BMC Nephrol. 2017 Nov 25;18(1):337. doi: 10.1186/s12882-017-0754-8.

Furuta S, Nakagomi D, Kobayashi Y,et al. Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial. JAMA. 2021 un 1;325(21):2178-2187. doi: 10.1001/jama.2021.6615.

Kallenberg CG. Key advances in the clinical approach to ANCA-associated vasculitis. Nat Rev Rheumatol. 2014 Aug;10(8):484-93. doi: 10.1038/nrrheum.2014.104. Epub 2014 Jul 1

Yates M, Watts R. ANCA-associated vasculitis. Clin Med (Lond). 2017 Feb;17(1):60-64. doi: 10.7861/clinmedicine.17-1-60.

Florian A, Slavich M, Blockmans D, Dymarkowski S, Bogaert J. Cardiac involvement in granulomatosis with polyangiitis (Wegener granulomatosis). Circulation. 2011 Sep 27;124(13):e342-4. doi: 10.1161/CIRCULATIONAHA.111.030809.

Misra DP, Shenoy SN. Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk. Rheumatol Int. 2017 Jan;37(1):151-167. doi: 10.1007/s00296-016-3435-1. Epub 2016 Feb 17.

Lacoste C, Mansencal N, Ben M'rad M, Goulon-Goeau C, Cohen P, Guillevin L, Hanslik T. Valvular involvement in ANCA-associated systemic vasculitis: a case report and literature review. BMC Musculoskelet Disord. 2011 Feb 23;12:50. doi:10.1186/1471-2474-12-50.

McGeoch L, Carette S, Cuthbertson D, et al. Vasculitis Clinical Research Consortium. Cardiac Involvement in Granulomatosis with Polyangiitis. J Rheumatol. 2015 Jul;42(7):1209-12. doi: 10.3899/jrheum.141513. Epub 2015 May 1.

Filice G, Richard I, Patel P, et al. Complete Heart Block Secondary to Microscopic Polyangiitis: A Rare Case Presentation. Cureus. 2020 May 21;12(5):e8227. doi: 10.7759/cureus.8227.

N Kinoshita, T Nawata, S Okuda, et al. Cardiac phenotypes in the acute-phase of microscopic polyangiitis involves dilatation of the left atrium caused by LV diastolic dysfunction, European Heart Journal, Volume 42, Issue Supplement_1, October 2021, ehab724.2756.

Dennert RM, van Paassen P, Schalla S,et al. Cardiac involvement in Churg- Strauss syndrome. Arthritis Rheum. 2010 Feb;62(2):627-34. doi:10.1002/art.27263.

Vinit J, Bielefeld P, Muller G,et al. Heart involvement in Churg-Strauss syndrome: retrospective study in French Burgundy population in past 10 years. Eur J Intern Med. 2010 Aug;21(4):341-6. doi: 10.1016/j.ejim.2010.05.004. Epub 2010 Jun 11.

Lhote F, Guillevin L. Churg-Strauss syndrome In: Hochberg MC, Silman AJ, Smolen JS Weinblatt ME, Weisman MH, eds. Rheumatology. 3rd ed. Philadelphia: Elsevier; 2003 p.1649-55).

Ledford DK. Immunologic aspects of vasculitis and cardiovascular disease. JAMA. 1997 Dec 10;278(22):1962-71.

Knockaert DC. Cardiac involvement in systemic inflammatory diseases. Eur Heart J. 2007 Aug;28(15):1797-804. doi: 10.1093/eurheartj/ehm193. Epub 2007 Jun 11.

Misra DP, Shenoy SN. Cardiac involvement in primary systemic vasculitis and potential drug therapies to reduce cardiovascular risk. Rheumatol Int. 2017 Jan;37(1):151-167. doi: 10.1007/s00296-016-3435-1. Epub 2016 Feb 17.

Miszalski-Jamka T, Szczeklik W, Sokołowska B,et al.Standard and feature tracking magnetic resonance evidence of myocardial involvement in Churg-Strauss syndrome and granulomatosis with polyangiitis (Wegener's) in patients with normal electrocardiograms and transthoracic echocardiography. Int J Cardiovasc Imaging. 2013 Apr;29(4):843-53. doi: 10.1007/s10554-012-0158-6. Epub 2012 Dec 5.

Sridharan S, Nanthakumaran S, Somagutta MR, et al. The Critical Role of Cardiac Magnetic Resonance Imaging in Evaluating Patients With Eosinophilic Granulomatosis With Polyangiitis. Cureus. 2020 Sep 6;12(9):e10279. doi: 10.7759/cureus.10279.

Morgan MD, Turnbull J, Selamet U, et al. Increased incidence of cardiovascular events in patients with antineutrophil cytoplasmic antibody-associated vasculitides: a matched-pair cohort study. Arthritis Rheum. 2009 Nov;60(11):3493-500. doi: 10.1002/art.24957.

Terrier B, Chironi G, Pagnoux C, et al. French Vasculitis Study Group. Factors associated with majör cardiovascular events in patients with systemic necrotizing vasculitides: results of a longterm followup study. J Rheumatol. 2014 Apr;41(4):723-9. doi: 10.3899/jrheum.130882. Epub 2014 Mar 1.

Dennert RM, van Paassen P, Schalla S,et al. Cardiac involvement in Churg- Strauss syndrome. Arthritis Rheum. 2010 Feb;62(2):627-34. doi:10.1002/art.27263.

Hazebroek MR, Kemna MJ, Schalla S, Sanders-van Wijk S, Gerretsen SC, DennertR, Merken J, Kuznetsova T, Staessen JA, Brunner-La Rocca HP, van Paassen P,Cohen Tervaert JW, Heymans S. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis. Int J Cardiol. 2015 Nov 15;199:170-9. doi: 10.1016/j.ijcard.2015.06.087.

Pagnoux C, Guillevin L. Cardiac involvement in small and medium-sized vessel vasculitides. Lupus. 2005;14(9):718-22. doi: 10.1191/0961203305lu2207oa.